Has Maria Provenzano received payments from drug or device companies?

Yes. Drug and device makers reported $4,475 in general payments to Maria Provenzano across 249 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maria Provenzano did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maria Provenzano come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maria Provenzano

Family · Red Bank, NJNPI 1386461952

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Johnson & Johnson at 39.5% of the total. Among family clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,475in general payments, 2019–2025

Across 249 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
AbbVie$382
Mallinckrodt Hospital Products Inc.$314
AstraZeneca$282
E.r. Squibb & Sons, L.L.C.$268
UCB, Inc.$248
plus $1K from 14 others

What the payments were for

Food & beverage$4,38598%
Education$902%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	100	$1,769
AbbVie	31	$382
Mallinckrodt Hospital Products Inc.	7	$314
AstraZeneca(2 entities)	15	$282
E.r. Squibb & Sons, L.L.C.	24	$268
UCB, Inc.	13	$248
Amgen	7	$220
ANI Pharmaceuticals, Inc.	12	$204
Pfizer	14	$204
Janssen Scientific Affairs, LLC	2	$175
Aurinia Pharma U.S., Inc.	5	$79
Radius Health, Inc.	3	$69
Phathom Pharmaceuticals, Inc.	4	$58
Novartis	2	$44
Pacira Pharmaceuticals Incorporated	3	$43
Sandoz	2	$31
Genentech USA, Inc.	2	$30
Fresenius Kabi USA, LLC	1	$19
Invivyd Inc	1	$19
Organon	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,475 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Other family in Red Bank

Jennifer DemaioMorristown$412K
Kara TrlicaCranbury$186K
Nicole BauerParamus$161K
China BattistaWall Township$142K
Nancy EisenbergerVoorhees$82K
Jennifer AbitabiloGlen Ridge$54K
Megan FiloramoMorristown$53K
Shawn DenningToms River$29K
Kimberly ClementeEatontown$25K
Toni Michelle SeibertColumbus$23K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →